Search research articles
Contact Us
Filters
Showing results (291-300 of 655) with videos related to
Page
of 66
Sort By:
Cancer Investigation
|
March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development Network
D Lacombe, A Butler-Smith, P Therasse, et al.
Journal of Neuro-Oncology
|
December 3, 1999
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma
M J van den Bent, L Pronk, P A Sillevis Smitt, et al.
Fetal Diagnosis and Therapy
|
November 19, 2011
Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: a systematic review
E J Verweij, J M E van den Oever, M A de Boer, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 1997
Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients
S H Goey, J Verweij, R L Bolhuis, et al.
British Journal of Cancer
|
July 4, 1998
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line
J Ma, M Maliepaard, K Nooter, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
L van Zuylen, M O Karlsson, J Verweij, et al.
Anti-Cancer Drugs
|
June 8, 2001
Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells
W Yamamoto, J Verweij, P de Bruijn, et al.
Neurology
|
January 1, 1996
Peripheral neurotoxicity induced by docetaxel
P H Hilkens, J Verweij, G Stoter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Outbreak of amebiasis in a family in The Netherlands
S G Vreden, L G Visser, J J Verweij, et al.
Anti-Cancer Drugs
|
November 26, 1999
Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans
W J Loos, J Verweij, H J Gelderblom, et al.
Page
of 66
Search research articles
Search
Showing results (291-300 of 655) with videos related to
Sort By:
Page
of 66
Cancer Investigation
|
March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development Network
D Lacombe, A Butler-Smith, P Therasse, et al.
Journal of Neuro-Oncology
|
December 3, 1999
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma
M J van den Bent, L Pronk, P A Sillevis Smitt, et al.
Fetal Diagnosis and Therapy
|
November 19, 2011
Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: a systematic review
E J Verweij, J M E van den Oever, M A de Boer, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 1997
Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients
S H Goey, J Verweij, R L Bolhuis, et al.
British Journal of Cancer
|
July 4, 1998
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line
J Ma, M Maliepaard, K Nooter, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
L van Zuylen, M O Karlsson, J Verweij, et al.
Anti-Cancer Drugs
|
June 8, 2001
Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells
W Yamamoto, J Verweij, P de Bruijn, et al.
Neurology
|
January 1, 1996
Peripheral neurotoxicity induced by docetaxel
P H Hilkens, J Verweij, G Stoter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Outbreak of amebiasis in a family in The Netherlands
S G Vreden, L G Visser, J J Verweij, et al.
Anti-Cancer Drugs
|
November 26, 1999
Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans
W J Loos, J Verweij, H J Gelderblom, et al.
Page
of 66